Untitled

Access the recording.

Download a copy of this content.

HealthTrust presents… “Nothing To Sneeze At: Influenza Updates”

There have been changes to the influenza vaccination recommendations for the 2019-2020 influenza season compared to the 2018-2019 season. Additionally, new treatment options for influenza have emerged since the last published IDSA guidelines in 2009. During this presentation, the development and clinical presentation of influenza will be discussed, along with complications resulting from the disease. Influenza vaccine recommendations will be reported as well as updates made by the Advisory Committee on Immunization Practices (ACIP) for the 2019-2020 influenza season for both pediatric and adult patients. Influenza testing will be reviewed as well as both non-pharmacological and pharmacological treatment options.

Learning Objectives for pharmacists & nurses  |  At the end of this session, participants should be able to:

1. Apply current influenza vaccine recommendations to a variety of patient situations.
2. Recommend influenza treatment for a patient based on specific factors including patient
   age and duration of illness.
3. Differentiate between currently available antiviral medications, their adverse effects and
   their contraindications.

Learning Objectives for pharmacy technicians  |  At the end of this session, participants should be able to:

1. Describe methods that can be taken to prevent the spread of influenza.
2. Identify patients who are eligible to receive an influenza vaccine.

Presenter:

Lisa Papai, PharmD, RPh  | PGY1 Pharmacy Practice Resident  |  Memorial Hospital of South Bend

Target Audience: Nurses, Pharmacists & Pharmacy Technicians

Continuing Education Information: 1.0 contact hours approved for Nurses, Pharmacists & Pharmacy Technicians. Belmont University College of Pharmacy  is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Belmont University School of Nursing is an approved provider of continuing nursing education by the Tennessee Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  The ACPE Universal Activity Numbers for this activity are 0863-9999-20-026-L01-P and 0863-9999-20-026-L01-T.

Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.

Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.  A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.